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Summary
A subset of families with autosomal dominant retinitis
pigmentosa (RP) display reduced penetrance with some
asymptomatic gene carriers showing no retinal
abnormalities by ophthalmic examination or by
electroretinography. Here we describe a study of three
families with reduced-penetrance RP. In all three families
the disease gene appears to be linked to chromosome
19q13.4, the region containing the RP11 locus, as
defined by previously reported linkage studies based on
five other reduced-penetrance families. Meiotic
recombinants in one of the newly identified RP11
families and in two of the previously reported families
serve to restrict the disease locus to a 6-cM region
bounded by markers D19S572 and D19S926. We also
compared the disease status of RP11 carriers with the
segregation of microsatellite alleles within 19q13.4 from
the noncarrier parents in the newly reported and the
previously reported families. The results support the
hypothesis that wild-type alleles at the RP11 locus or at
a closely linked locus inherited from the noncarrier
parents are a major factor influencing the penetrance of
pathogenic alleles at this locus.
Introduction
Retinitis pigmentosa (RP) is a progressive degeneration
of the rod and cone photoreceptor cells in the retina
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leading to visual loss and often to blindness by middle
age. Most cases have no associated extraocular disease
(i.e., nonsyndromic RP) whereas a minority of cases have
other disease, such as deafness associated with RP in
Usher syndrome. Nonsyndromic RP and many forms of
syndromic RP exhibit nonallelic heterogeneity. For ex-
ample, nonsyndromic RP can be inherited as a domi-
nant, a recessive, an X-linked, or a digenic trait (for a
review, see Dryja and Li 1995). Within the category of
nonsyndromic dominant RP, mutations in genes encod-
ing rhodopsin and peripherin/RDS have been identified
as causes (Dryja et al. 1990; Farrar et al. 1991; Kajiwara
et al. 1991). Also, unidentified genes causing nonsyn-
dromic dominant RP have been assigned through linkage
studies to chromosomes 1cen (Xu et al. 1996b), 7p (In-
glehearn et al. 1993, 1994; Keen et al. 1995), 7q (Jordan
et al. 1993; McGuire et al. 1995; Milla´n et al. 1995),
8q (Blanton et al. 1991; Xu et al. 1996a), 17p (Green-
berg et al. 1994; Goliath et al. 1995; Kojis et al. 1996;
Tarttelin et al. 1996), 17q (Bardien et al. 1995; McGuire
et al. 1996; Mohamed et al. 1996), and 19q (Al-Magh-
theh et al. 1994, 1996; Xu et al. 1995). At least one
additional dominant RP locus exists (Xu et al. 1996b).
In those families with dominant RP showing linkage
to chromosome 7p or 19q (specifying the RP9 and RP11
loci, respectively), there is variable expressivity, with
some obligate carriers being asymptomatic and showing
no evidence of retinal degeneration through ocular ex-
amination or by electroretinography (Evans et al. 1995;
Kim et al. 1995; Nakazawa et al. 1996). This is in strik-
ing contrast to what is found in most families with
dominant RP, in which even young patients without sub-
jective visual abnormalities invariably can be shown
through ophthalmic evaluation to have signs of retinal
degeneration. The basis for the reduced penetrance of
mutations at the RP9 and RP11 loci is unknown.
In this article, we present linkage data indicating that
dominant RP in all of three reduced-penetrance families
ascertained in our laboratory is likely to be due to mu-
tations at the RP11 locus. In addition, we compile and
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analyze data, derived from these families and from those
previously reported, that relate to possible causes for the
reduced penetrance of RP11 mutations.
Patients, Material, and Methods
Fifty-six family members from the three ascertained
families participated in this study, as well as 43 unrelated
control individuals (40 without RP or an allied disease
and 3 members from a family with Usher syndrome, of
whom 1 is an affected individual and 2 are individuals
who married into the family). Informed consent was
obtained from every participant, and the tenets of the
Declaration of Helsinki were followed. This study was
approved by the institutional review boards of the Har-
vard Medical School and the Massachusetts Eye and Ear
Infirmary. From each participating patient, 10–50 ml of
venous blood were obtained. Leukocyte nuclei were pre-
pared from the blood samples and were stored for as
long as 10 years, at 70C, before DNA was purified
by use of standard methods.
Dinucleotide polymorphic markers were analyzed by
amplification by PCR of the relevant genomic region.
Amplification primers were synthesized (Gibco/Life
Technologies) in accordance with either published se-
quences (for D19S572 and D19S926) (Dib et al. 1996)
or sequences from the Genome Database (for D19S180)
(http://gdbwww.gdb.org). Prior to amplification, 20
pmol of one of each pair of primers was 32P-end-labeled
by use of polynucleotide kinase (New England Biolabs)
and 60 mCi g-labeled 32P (6,000 Ci/mmol; New England
Nuclear); equal aliquots of the labeled primer were
added to as many as 50 PCRs. The relevant genomic
regions were amplified from 50–100 ng of genomicDNA
in the wells of microtiter plates. The PCRwas performed
in 20 ml containing 50 mM KCl, 20 mM tris, pH 8.4
or 8.6, 2 mg BSA/ml, 1.5 mM MgCl2, 0.25 units
AmpliTaq (Perkin Elmer), 18–20 pmol of each primer,
including 0.4–1.0 pmol of the primer that was 32P-
labeled. The solution was placed under 40 ml of mineral
oil. PCR entailed 22 rounds of polymerization with an-
nealing temperatures of 50–56C depending on the spe-
cific microsatellite analyzed. Amplified DNAwas diluted
1:1 (v:v) with a solution of 95% formamide, 20 mM
EDTA, 0.05% bromphenol blue, and 0.05% xylene cy-
anol. Fragments were separated by electrophoresis
through 6% denaturing polyacrylamide gels.
Marker allele frequencies were based on a sample of
57 or 58 unrelated individuals, including 43 unrelated
controls (42 for D19S180); 13 individuals who had mar-
ried into these families; and 1 gene carrier each from
two of the families who were the only individuals in the
study who possessed an uncommon allele at one of the
marker loci. Two-point linkage analysis was performed
by use of the MLINK program of the LINKAGE pack-
age, version 5.1 (Lathrop et al. 1984). The genetic model
used in the linkage analysis for the disease locus was for
autosomal dominant inheritance with reduced pene-
trance estimated at .49 for the susceptible genotype, on
the basis of data from the three families. LOD scores
were not changed substantially if the penetrance value
was within the range of .6–.7 that was used by another
group (Evans et al. 1995; Al-Maghtheh et al. 1996). The
disease-gene frequency was set at .0001, and all affected
individuals were assumed to be heterozygous carriers of
the disease allele, whereas all individuals marrying into
the families were assumed to be homozygous wild type.
Multipoint analysis was performed with the GENE-
HUNTER program (Kruglyak et al. 1996). Parameters
in the multipoint analysis were the same as those de-
scribed for the two-point analysis. The marker order and
distances used in the multipoint analysis were as follows:
D19S180–5.7 cM–D19S572–6.2 cM–D19S926. The
distance between D19S572 and D19S926 is as published
by Dib et al. (1996) (also see the Ge´ne´thon database
[http://www.genethon.fr]). Since no reliable published
distance between D19S180 and D19S572 was available,
we used the distance between D19S571 and D19S572
(Dib et al. 1996) as a conservative estimate, since
D19S180 has been reported to be located between these
two markers (Al-Maghtheh et al. 1996).
The correlation between the inheritance of alleles from
the noncarrier parents and the presence of disease in
carrier offspring was studied by use of two types of sib-
pair analyses based on data derived from the families
described in this article and from those reported previ-
ously by Xu et al. (1995) and by Al-Maghtheh et al.
(1996). First, the sibships with at least one affected and
one unaffected carrier were analyzed exclusively. All sib
pairs in these sibships were considered independently
and were arranged into a 2#2 contingency table ac-
cording to disease status (discordant vs. concordant) and
inheritance of RP11-linked marker haplotypes from the
noncarrier parent (same vs. different RP11 haplotypes).
A few sib pairs were excluded from the analysis because
the inheritance of RP11 alleles from the noncarrier par-
ent could not be deduced with certainty, in some cases
because of crossovers in the RP11 region.
A second sib-pair analysis included all carrier sib pairs
of all sibships and used the program SIBPAIR (Satsangi
et al. 1996). This program allows one to look at affected
and unaffected carrier siblings, in contrast with most
other nonparametric-linkage-analysis programs that
normally perform an affected-sib-pair analysis only. The
test statistic is equivalent to a LOD score calculated un-
der a simple recessive model. To correct for within-sib-
ship correlation when there is more than one sib pair in
a sibship, the program assigns a weight of to sib-n 1
ships of size n. When the parents’ genotypes are not
available, the likelihood is calculated by considering all
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Figure 1 Schematic pedigrees of three families (1295, 2474, and 1562) with dominant reduced-penetrance RP. Blackened symbols indicate
affected individuals. The alleles at microsatellite loci D19S180, D19S572, and D19S926 are listed (from top to bottom, respectively) below the
symbols for the individuals who donated blood samples for this research. Each family has a different cosegregating haplotype.
possible genotypes for the missing parents, on the basis
of allele frequencies provided by the user.
For this second analysis, the three pedigrees described
in the present study, the pedigrees described byAl-Magh-
theh et al. (1996) (ADRP5, ADRP29, RP1907, and
ADRP2), and the pedigree described by Xu et al. (1995)
were subdivided into their nuclear components. There
were 27 nuclear pedigrees containing at least one carrier
sib pair. In the families from this study, marker allele
frequencies were calculated as described above. Marker
allele frequencies for the families reported by otherswere
estimated from the data in the respective papers by use
of the program ILINK of the LINKAGE package (La-
throp et al. 1984). In the analysis of the pedigree de-
scribed by Xu et al. (1995), marker D19S418 was used
in place of marker D19S926. In order to ensure that
only the contributions from the noncarrier parents were
included in the analysis, we coded all carrier parents as
if they were homozygous at all marker loci. The data
from the pedigrees presented here, the pedigree from the
study by Xu et al. (1995), and the pedigrees described
by Al-Maghtheh et al. (1996) were analyzed separately,
and the three resulting LOD scores were summed to give
the total LOD scores for each marker.
Results
Ascertainment of Families
Three families with dominant RP with reduced pen-
etrance were ascertained from the files of the Berman-
Gund Laboratory (for schematic pedigrees see fig. 1).
The clinical findings for two of these families (1562 and
2474) have been reported elsewhere, and, in particular,
those reports documented the absence of retinal degen-
eration in some obligate carriers (Berson et al. 1969;
Berson and Simonoff 1979). Previously reported linkage
data from family 1562 clearly showed that the disease
locus in this family was not linked to RP9 on chro-
mosome 7p (Kim et al. 1994). The third family (1295)
had not been reported previously in the scientific liter-
ature. This family was categorized as having reduced-
penetrance RP, since individual III-4 was not found to
have RP through clinical examination despite her status
as an obligate carrier. Family members II-2, II-3, and
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Table 1
Two-Point LOD-Score Analysis for Families 1562, 2474, and 1295
LOCUS AND FAMILY
LOD SCORE AT RECOMBINATION FRACTION OF
LODmax vmax.0 .01 .05 .1 .2 .3 .4
D19S180:
1562  .96 .33 .10 .07 .11 .08
2474 3.64 .89 .28 .08 .02 .02 .01
1295 .58 .56 .49 .40 .25 .13 .05
Total  1.29 .12 .22 .33 .26 .14 .33 .19
D19S572:
1562  1.34 1.82 1.83 1.49 1.00 .47
2474 .82 .80 .72 .61 .43 .28 .14
1295 1.70 1.66 1.51 1.32 .93 .55 .23
Total  3.81 4.05 3.76 2.86 1.83 .84 4.07 .04
D19S926:
1562 2.66 2.61 2.40 2.13 1.59 1.05 .52
2474 1.35 1.32 1.20 1.04 .74 .46 .21
1295 1.52 1.48 1.34 1.16 .80 .47 .18
Total 5.53 5.41 4.93 4.33 3.13 1.97 .92 5.53 .00
Figure 2 Plot of multipoint LOD scores as a function of genetic
distance from locus D19S180. The LOD scores were summed from
data from the three families in this study.
III-5 are also obligate carriers who are asymptomatic by
history, but they have not been examined by us.
Linkage to 19q
In order to test the hypothesis that RP in families
1562, 2474, and 1295 is due to the RP11 locus on chro-
mosome 19q, we examined the segregation of alleles at
polymorphic loci from the relevant chromosomal region
(fig. 1). The results of two-point and multipoint linkage
analyses are shown in table 1 and in figure 2, respec-
tively. The maximum summed multipoint LOD score
was 6.47 at from D19S926. Maximummultipointv  0
LOD scores (LODmax) were 3.03, 2.05, and 1.42 for
families 1562, 1295, and 2474, respectively. These
LODmax scores strongly support the hypothesis that the
disease locus in family 1562 is RP11, since the LODmax
score is 13.0. The disease in families 2474 and 1295 also
is likely to be due to defects at the RP11 locus, although
the LODmax scores are !3.0 because of the smaller size
of these families.
The detection of a meiotic recombinant between
D19S572 and D19S926 in family 1562 (individual IV-
34 in fig. 1) places locus D19S572 as a centromeric
boundary for the possible location of the RP11 locus.
Two other informative recombinants have been identi-
fied in families ADRP29 and ADRP2, reported by Al-
Maghtheh et al. (1996); these recombinants place locus
D19S926 as a telomeric boundary for the chromosomal
segment containing the RP11 gene.
Evaluation of Possible Models for Reduced Penetrance
To test models for reduced penetrance in families
showing linkage to the RP11 locus, data were obtained
from the three pedigrees presented in this article, as well
as from the five pedigrees described in previous studies
(Xu et al. 1995; Al-Maghtheh et al. 1996). The possi-
bility that penetrance was sex related was assessed by
tabulating the number of affected versus unaffected in-
dividuals of each gender who were identified as carriers
by clinical symptoms or by the RP11-linked haplotype.
There were more females than males in the group of
affected carriers (47 vs. 35, respectively) and in the group
of unaffected carriers (23 vs. 10). Although there was a
statistically significant excess of female carriers overall
(70 vs. 45; , , ), the ratio of af-2x  5.4 df  1 P ! .025
fected versus unaffected female carriers was not statis-
tically different from that of male carriers ( ,2x  1.04
, ). The excess of female carriers may havedf  1 P 1 .25
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been due to an ascertainment bias caused perhaps by
females being more available or more agreeable than
males to participation in these studies. In any event, since
the female excess was present among both affected and
unaffected carriers, it is unlikely that sex is amajor factor
influencing penetrance.
A model whereby penetrance is determined by the sex
of the parent transmitting the pathogenic RP11 allele
appeared to be incorrect, since the ratio of affected ver-
sus unaffected carrier offspring from carrier mothers (54
vs. 17, respectively) was not statistically different
( , , ) from the ratio of affected2x  1.67 df  1 P 1 .1
versus unaffected carrier offspring from carrier fathers
(23 vs. 14). However, because of incomplete ascertain-
ment, we cannot conclusively rule out the sex of the
carrier parent as a factor influencing penetrance.
The third model that we considered was that the wild-
type RP11 alleles from the noncarrier parent specify pen-
etrance. Since RP11 remains unidentified, the molecular
nature of any possible variation among wild-type alleles
remains unknown. However, we were able to test the
validity of this model by examining sibships with more
than one carrier. This was done in two different ways.
The first analysis was confined to those sibships in which
there was at least one affected and one unaffected carrier.
If the model is correct, the noncarrier parent of such a
sibship necessarily would be heterozygous for any wild-
type alleles that specify the penetrance of the pathogenic
RP11 allele inherited from the carrier parent. Among the
offspring who inherit a pathogenic allele from the carrier
parent, the affected siblings would all inherit one RP11
allele from the noncarrier parent, and the unaffected
siblings would inherit the other.
We found six sibships in which there was at least one
affected and one unaffected carrier (determined by link-
age to the RP11 region) and in which the origin of the
parental alleles in this chromosomal region could be de-
termined. Within these sibships were 26 pairs of carrier
siblings. These sib pairs were placed into four categories
according to the concordance or the discordance of phe-
notype (affected vs. unaffected) and of genotype (inher-
itance of the same vs. different marker haplotypes from
the noncarrier parent) (table 2). The distribution of sib
pairs was nonrandom ( , by use of Fisher’sP  .00005
exact test). In particular, all 10 sib pairs in which both
members had the same phenotype inherited the same
RP11-linked haplotype from the noncarrier parent; 13
of 16 sib pairs with different phenotypes inherited dif-
ferent haplotypes.
A second sib-pair analysis was performed in which all
multicarrier sibships were analyzed, including those in
which all carriers had the same disease status. For this
latter sib-pair analysis, we calculated the likelihood that
a modifier gene transmitted by the noncarrier parents
was linked to each marker analyzed separately. The re-
sults from the SIBPAIR program again support the ex-
istence of a modifier locus in this region, with LOD
scores of 3.63 ( ), 3.02 ( ), and 4.16P  .00002 P  .0001
( ) for the markers D19S180, D19S572, andP  .000006
D19S926, respectively.
Discussion
The tentative assignment of RP in all three families
described in this study to the RP11 locus supports the
speculation of Al-Maghtheh et al. (1996) that RP11 is
a relatively frequent cause of dominant RP. Including
these three families, a total of eight families with dom-
inant RP demonstrate linkage between the disease locus
and chromosome 19q13.4 (Xu et al. 1995; Al-Maghtheh
et al. 1996). A larger number of families have been re-
ported for only two of the seven loci implicated as caus-
ing dominant RP, rhodopsin and RDS. The rhodopsin
locus appears to be a recognizably more frequent cause
of dominant RP, accounting for ∼19%–26% of families
(Vaithinathan et al. 1994). The RDS gene, although ac-
counting for disease in several more reported families
than RP11, has been under investigation since its iden-
tification in 1991 (Farrar et al. 1991; Kajiwara et al.
1991). It is possible that even greater numbers of RP11
cases will be discovered once this gene is identified.
The reduced penetrance of mutations at the RP11 lo-
cus is noteworthy. As noted in earlier publications, oph-
thalmic examinations of asymptomatic carriers in this
study’s families revealed either no abnormal findings or
minimal reductions in electroretinogram (ERG) ampli-
tudes and minimal delays in ERG implicit times that
were not diagnostic of RP (Berson et al. 1969; Berson
and Simonoff 1979). The analyses presented in this ar-
ticle are relevant to potential genetic mechanisms re-
sponsible for the reduced penetrance. The data from the
three families reported here, together with those from
the families reported elsewhere by other groups, suggest
that it is unlikely that the development of RP in a carrier
is related to the carrier’s sex or to whether a mutant
RP11 allele was inherited from the mother or father.
However, alleles inherited from the noncarrier parent
appeared to have an important role, as discussed below.
On the basis of an analysis of sib pairs, there was a
statistically significant correlation between the devel-
opment of RP in a carrier and the inheritance of the
region around RP11 from the noncarrier parent. This
correlation might be due to penetrance being highly in-
fluenced by otherwise silent alleles at the RP11 locus or
by a closely linked locus. Perhaps a biallelic polymor-
phism at the RP11 locus exists, so that homozygotes or
heterozygotes for either allele have no RP. The combi-
nation of one of these two alleles in trans with a mutant
pathogenic RP11 allele would produce RP, and the com-
bination of the other wild-type allele in trans with a
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Table 2
Phenotype/Genotype Correlation of Sib Pairs from Sibships with
at Least One Discordant Pair
SOURCE AND SIB PAIR
PHENOTYPE/GENOTYPE CORRELATION
Same/
Same
Same/
Different
Different/
Same
Different/
Different
From Xu et al. (1995):
II-4/II-6 X
II-4/II-11 X
II-6/II-11 X
From Al-Maghtheh et al. (1996):
ADRP5:
IV-6/IV-9 X
IV-6/IV-10 X
IV-6/IV-11 X
IV-6/IV-12 X
IV-6/IV-14 X
IV-9/IV-10 X
IV-9/IV-11 X
IV-9/IV-12 X
IV-9/IV-14 X
IV-10/IV-11 X
IV-10/IV-12 X
IV-10/IV-14 X
IV-11/IV-12 X
IV-11/IV-14 X
IV-12/IV-14 X
IV-15/IV-16 X
IV-15/IV-19 X
IV-16/IV-19 X
V-1/V-4 X
ADRP29:
IV-2/IV-5 X
IV-2/IV-7 X
IV-5/IV-7 X
RP1907:
IV-1/IV-2 X
Total no. 10 0 3 13
mutant RP11 allele would not produce RP. If the non-
carrier parent is a homozygote for this silent polymor-
phism, all offspring inheriting a pathogenic RP11 allele
from the carrier parent would have the same disease
status (either all would be affected or all would be un-
affected). In such cases, examination of the segregation
of 19q13.4 alleles would be uninformative, since trans-
mission of copies of 19q13.4 from the noncarrier parent
would correlate only by chance with the development
of RP in carriers. However, in sibships with at least one
affected and one unaffected carrier, the noncarrier parent
necessarily would be a heterozygote for the presumed
modifying polymorphism. In these cases, one version of
19q13.4 should be found in all affected carriers, and the
other version should be found in all unaffected carriers.
The sib-pair analysis for six suitably selected sibships
supports this model, although imperfectly. Pairs of car-
rier siblings with the same phenotype always inherited
the same copy of 19q13.4 from the noncarrier parent.
Among pairs of carrier siblings with contrasting phe-
notypes (i.e., one affected and one unaffected), most in-
herited different copies of 19q13.4 from the noncarrier
parent. A separate analysis of the entire set of sib pairs,
including those from sibships without phenotypically
discordant pairs, also strongly supported the existence
of a modifier gene in the 19q13.4 region.
Possible explanations for the presence of a few pairs
of siblings who had contrasting phenotypes but who had
inherited the same copies of 19q13.4 from the noncarrier
parents include the existence of other factors modifying
penetrance (such as other genes or environmental or di-
etary factors) or the miscategorization of the phenotype
of one member of a pair (perhaps owing to inaccuracy
in the disease status reported by relatives).
To our knowledge, there are very few precedents for
penetrance specified by wild-type alleles in trans at a
disease locus. The clearest analogue is the hemolytic ane-
mia (hereditary elliptocytosis) caused by dominant mu-
tations in the gene coding for the a subunit of spectrin
(Gratzer 1994). Spectrin is a cytoskeletal protein that is
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essential for the normal morphology of red blood cells.
Mutant versions of a-spectrin produce malformed red
blood cells and a severe hemolytic anemia. However,
carriers of dominant mutations may be either severely
affected and dependent on blood transfusions through-
out life or unaffected. The penetrance of mutations is
specified by a high-frequency, otherwise-silent polymor-
phism at this locus that determines the relative level of
expression of a-spectrin alleles (Wilmotte et al. 1993).
A patient with a high-expressing wild-type allele in trans
of a pathogenic mutation will be unaffected or very
mildly affected. A patient with a low-expressing wild-
type allele in trans will suffer chronic, severe hemolytic
anemia unless the pathogenic mutation is by chance also
on a low-expressing allele (Randon et al. 1994).
To a lesser extent, an intragenic polymorphism also
influences the severity of fatal familial insomnia or of
Creutzfeld-Jakob disease, which are caused by different
mutations in the prion-protein gene (Goldfarb et al.
1992), and the effect appears to be mediated by altered
conformations of the mutant protein (Monari et al.
1994). However, the modulation of disease severity is
slight and in sharp contrast to the presence or the ab-
sence of the disease seen in hereditary elliptocytosis or
in RP11-linked low-penetrance RP. The biochemical
mechanisms by which wild-type alleles at the RP11 locus
or at a closely linked locus influence severity remain
obscure and probably will remain so until the future
identification of the RP11 gene.
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